|
2024 Conference Publication Genomic variation in symptom expression in men with castrate resistant prostate cancerGood, Phillip, Foster, Karyn, Greer, Ristan, Oliveira, Niara, Vayne-Bossert, Petra, Ewing, Adam and Hardy, Janet (2024). Genomic variation in symptom expression in men with castrate resistant prostate cancer. ANZSPM 2024 Biennial Conference, Adelaide, SA, United States, 5-8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.61 |
|
2024 Conference Publication Clinical studies of medicinal cannabis in palliative care – The development of a research programGood, Phillip, Foster, Karyn, Greer, Ristan, Pelecanos, Anita, Huggett, Georgie, Kearney, Alison, Gurgenci, Taylan and Hardy, Janet (2024). Clinical studies of medicinal cannabis in palliative care – The development of a research program. ANZSPM 2024 Biennial Conference, Adelaide, SA, United States, 5-8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.63 |
|
2024 Conference Publication A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trialsWeerasinghe, Aanjanee Dodanwela, Gurgenci, Taylan, Hardy, Janet and Good, Phillip (2024). A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.19 |
|
2024 Conference Publication A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancerGood, Phillip, Greer, Ristan, Pelecanos, Anita, Kearney, Alison, Huggett, Georgie, Gurgenci, Taylan and Hardy, Janet (2024). A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.11 |
|
2024 Conference Publication Drug interactions in people on cannabidiol – is there cause for concern?Downs, Georgia, Greer, Ristan, Moses, Geraldine, Gurgenci, Taylan, Good, Phillip and Hardy, Janet (2024). Drug interactions in people on cannabidiol – is there cause for concern?. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.62 |
|
2024 Conference Publication A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative careHardy, Janet Rea, Greer, Ristan, Gurgenci, Taylan, Kearney, Alison, Ladwa, Rahul, Huggett, Georgie and Good, Phillip (2024). A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2024.42.16_suppl.12020 |
|
2022 Conference Publication 'What price do you put on your health?' Medicinal Cannabis, financial toxicity, and patient perspectives on medication access in advanced cancerOlson, Rebecca, Smith, Alexandra, Good, Phillip, Dudley, Morgan and Hardy, Janet (2022). 'What price do you put on your health?' Medicinal Cannabis, financial toxicity, and patient perspectives on medication access in advanced cancer. The Australian Sociological Association (TASA) conference, Melbourne, VIC Australia, 29 November-2 December 2022. |
|
2022 Conference Publication Is there a role for medicinal cannabis in symptom management?Hardy, Janet (2022). Is there a role for medicinal cannabis in symptom management?. HOBOKEN: WILEY. |
|
2022 Conference Publication "What price do you put on your health?": Medical cannabis, financial toxicity, and patient perspectives on medication access in advanced cancerOlson, Rebecca, Smith, Alexandra, Good, Phillip, Dudley, Morgan and Hardy, Janet (2022). "What price do you put on your health?": Medical cannabis, financial toxicity, and patient perspectives on medication access in advanced cancer. The Australian Sociological Association Conference, Melbourne, VIC, Australia, 28 November - 2 December 2022. |
|
2017 Conference Publication A randomised, controlled, double blind study of oral methotrimeprazine versus oral haloperidol in patients with cancer and nausea not related to anticancer therapyHardy, J., Skerman, H., Franzen, K., Foster, K. and Yates, P. (2017). A randomised, controlled, double blind study of oral methotrimeprazine versus oral haloperidol in patients with cancer and nausea not related to anticancer therapy. ESMO Asia Congress, Singapore, 17-19 November 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdx676.004 |
|
2015 Conference Publication Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative careAgar, Meera, Lawlor, Peter, Quinn, Steve, Caplan, Gideon, Draper, Brian, Rowett, Debra, Devilee, Linda, Fazekas, Belinda, Sanderson, Christine, McCaffery, Nicola, Hardy, Janet, Le, Brian, Eckermann, Simon, Hill, Mark and Currow, David (2015). Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care. Annual Scientific Meeting of the American-Geriatrics-Society (AGS), National Harbor Md, May 10-17, 2015. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication Phase III randomized double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative careAgar, M., Lawlor, P., Quinn, S., Caplan, G., Draper, B., Rowett, D., Devilee, L., Fazekas, B., Sanderson, C., McCaffrey, N., Hardy, J., Le, B., Eckermann, S., Hill, M. and Currow, D. (2015). Phase III randomized double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care. Annual Scientific Meeting of the American-Geriatrics-Society (AGS), National Harbor, MD United States, May 10-17, 2015. Hoboken, NJ United States: Wiley-Blackwell . |
|
2014 Conference Publication Implementing a protocol for vitamin D screening and replacement in cancer patientsXu, Wen, Hardy, Janet, Lwin, Zarnie, Woodward, Natasha and Shannon, Catherine (2014). Implementing a protocol for vitamin D screening and replacement in cancer patients. Clinical Oncology Society of Australia Annual Scientific Meeting, Melbourne, VIC, Australia, 2-4 December 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Implementing a protocol for vitamin-D screening and replacement in cancer patientsXu, Wen, Hardy, Janet, Lwin, Zarnie, Woodward, Natasha and Shannon, Catherine (2014). Implementing a protocol for vitamin-D screening and replacement in cancer patients. COSA's 41st Annual Scientific Meeting. Joining Forces ‐ Accelerating Progress, Melbourne, VIC Australia, 2‐4 December 2014. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2013 Conference Publication Overview of N-of-1 study suite – lessons learned from three aggregated N-of-1 trialsMitchell, Geoff, Nikles, Jane, Carmont, Sue-Ann, Hardy, Janet, Good, Phillip, Agar, Meera, Clark, Katherine, Douglas, Carol, Vora, Rohan, Currow, David and Senior, H. (2013). Overview of N-of-1 study suite – lessons learned from three aggregated N-of-1 trials. PaCCSC 4th Annual Scientific Meeting and Research Forum 2013, Sydney, NSW, Australia, 20-21 Mar, 2013. |
|
2012 Conference Publication A randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer painCurrow, David C., Hardy, Janet, Quinn, Stephen, Fazekas, Belinda, Plummer, John, Eckermann, Simon, Agar, Meera, Spruyt, Odette and Debra, Rowett (2012). A randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication The effectiveness of methylphenidate in fatigue in advanced cancer: Aggregated n-of-1 trial resultsMitchell, G., Hardy, J., Carmont, S., Nikles, J., Senior, H., Schluter, P., Good, P., Agar, M., Clark, K., Vora, R. and Currow, D. (2012). The effectiveness of methylphenidate in fatigue in advanced cancer: Aggregated n-of-1 trial results. Australian and New Zealand Society of Palliative Medicine conference, Queenstown, New Zealand, 4 - 7 September 2012. |
|
2012 Conference Publication The effectiveness of methylphenidate in fatigue in advanced cancer: aggregated N-of-1 trailsMitchell, Geoffrey, Hardy, Janet, Carmont, Sue-Ann, Nikles, Jane, Senior, Hugh, Schluter, Philip, Good, Philip, Agar, Meera, Clark, Katherine, Vora,Rohan, Douglas, Carol and Currow, David (2012). The effectiveness of methylphenidate in fatigue in advanced cancer: aggregated N-of-1 trails. Ipswich Hospital Research Day, Ipswich, Qld, Australia, 1 September 2012. |
|
2011 Conference Publication A Randomised, Double-blind, Placebo Controlled, Multi-site Study of Subcutaneous Ketamine in the Management of Cancer PainCurrow, D. C., Hardy, J., Agar, M., Sanderson, C., Spruyt, O., Eckermann, S., Plummer, J. and Quinn, S. (2011). A Randomised, Double-blind, Placebo Controlled, Multi-site Study of Subcutaneous Ketamine in the Management of Cancer Pain. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm Sweden, Sep 23-27, 2011. OXFORD: ELSEVIER SCI LTD. |
|
2008 Conference Publication Investigating n-of-1 trials as a means of gathering palliative care evidenceCarmont, S., Currow, D., Hardy, J., Mitchell, G. K., Nikles, J., Schluter, P., Vora, R. and Yelland, M. (2008). Investigating n-of-1 trials as a means of gathering palliative care evidence. 8th Biennial Conference of the Australian and New Zealand Society of Palliative Medicine (ANZSPM), Darwin, NT, Australia, 23-26 September 2008. |
